Search results for rivaroxaban

The development of Xarelto® (rivaroxaban), a novel oral anticoagulant, has taken another step forward. Phase II results in patients with acute coronary syndrome (ACS) have been chosen for the Late Br read more »
Discuss   Add this link to...  Bury